Ceftiofur HCl (Pharma Grade)

Product Overview

Ceftiofur HCl (Pharma Grade) is a third-generation cephalosporin antibiotic with broad-spectrum activity against both Gram-positive and Gram-negative bacteria. While primarily developed as a veterinary drug, its API quality meets pharmaceutical-grade standards.

Ceftiofur inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). Its active metabolite, desfuroylceftiofur, maintains antimicrobial activity. This pharma-grade material is suitable for use as a pharmaceutical reference standard, in clinical research applications, and for pharmaceutical quality control purposes.

Quality Specifications

Purity	As per USP Veterinary monograph
Residual Solvents	Compliant with ICH Q3C
Heavy Metals	Compliant with pharmacopoeia limits
GMP Status	Manufactured under GMP conditions

Pharmaceutical Applications

• Pharmaceutical reference standard: Analytical method development and validation
• Clinical research: Investigational studies on cephalosporin pharmacology
• Pharmaceutical quality control: Reference material for QC laboratories
• Cephalosporin intermediate studies: Research on structure-activity relationships